Addressing Unmet Medical Needs in NeuroPsychiatry Through Precision Medicine
Our Mission
ReST develops breakthrough therapies to treat complex neuropsychiatric disorders. Our lead program, RST-101 is focused on the early treatment Post Traumatic Stress Disorder (PTSD).
Our Team
Anthony Franco, J.D.
General Manager
Gilles Rubinstenn, PhD, MBA
Chairman & Chief Innovation Officer
Reina Benabou, MD, PhD
Chief Medical Officer
Our Partners
